Technical Analysis for GBT - Global Blood Therapeutics, Inc.
Trend Table & Recent Alerts
|See historical GBT trend table...|
|Date||Alert Name||Type||% Chg|
|Apr 27||NR7||Range Contraction||-1.70%|
|Apr 25||Doji - Bearish?||Reversal||-5.08%|
|Apr 21||180 Bearish Setup||Bearish Swing Setup||-0.17%|
|Apr 20||NR7||Range Contraction||-2.85%|
|Apr 18||Lower Bollinger Band Walk||Other||-1.03%|
|Apr 17||Lower Bollinger Band Walk||Other||-0.17%|
|Apr 13||Fell Below 50 DMA||Bearish||0.17%|
|Apr 13||Lower Bollinger Band Walk||Other||0.17%|
|Apr 12||Lower Bollinger Band Walk||Other||-4.30%|
|Apr 12||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||-4.30%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Is GBT a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more GBT news...
|52 Week High||41.15|
|52 Week Low||13.35|
|200-Day Moving Average||21.707|
|50-Day Moving Average||32.44|
|20-Day Moving Average||31.4075|
|10-Day Moving Average||29.555|
|Average True Range||1.6886|
|Chandelier Exit (Long, 3 ATRs)||34.3842|
|Chandelier Exit (Short, 3 ATRs)||32.9158|
|Upper Bollinger Band||36.6337|
|Lower Bollinger Band||26.1813|
|Percent B (%b)||0.26|